TRIM28 and Β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers

PLoS ONE - United States
doi 10.1371/journal.pone.0113688
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

MicroRNA as Potential Biomarkers in Glioblastoma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2015English

Combined Analysis of Human and Experimental Murine Samples Identified Novel Circulating MicroRNAs as Biomarkers for Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2018English

Biomarkers in Transplantation—Proteomics and Metabolomics

Therapeutic Drug Monitoring
Pharmacology
2016English

Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2014English

Functional Characterization of Disease-Related Human Β-Actin Mutants

Biophysical Journal
Biophysics
2014English

Identification of TPD52 and DNAJB1 as Two Novel Bile Biomarkers for Cholangiocarcinoma by iTRAQ‑based Quantitative Proteomics Analysis

Oncology Reports
MedicineCancer ResearchOncology
2019English

Proteomics-Based Approach for Identification and Purification of Human Phosphate Binding Apolipoprotein From Amniotic Fluid

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2009English

Implementation of Proteomics Biomarkers in Nephrology: From Animal Models to Human Application?

Proteomics - Clinical Applications
Clinical Biochemistry
2018English

Biomarkers and Therapeutic Advances in Glioblastoma Multiforme

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy